Overview

HL60 cells


'HL60 cells' can also refer to...

HL60 cells

Retinoic acid treated HL60 cells express CEACAM1 (CD66a) and phagocytose Neisseria gonorrhoeae

Carnosic Acid and Promotion of Monocytic Differentiation of HL60-G Cells Initiated by Other Agents

2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, Induces Accelerated Production of Chemokines in HL-60 Cells

Purification and Characterization of a Novel Protamine Kinase in HL60 Cells

Se-Methylselenocysteine induces apoptosis through caspase activation in HL-60 cells

Gene expression of TPA induced differentiation in HL‐60 cells by DNA microarray analysis

Zinc Ions Prevent Processing of Caspase-3 during Apoptosis Induced by Geranylgeraniol in HL-60 Cells

Proteins in Human Myeloid Leukemia Cell Line HL60 Reacting with Retinoic Acid Monoclonal Antibodies

MicroRNA-196 inhibits HOXB8 expression in myeloid differentiation of HL60 cells

Telomere shortening in human HL60 cells by treatment with deoxyguanosine analogs

Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells

Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte

All-trans-retinoic acid increases cytosine arabinoside cytotoxicity in HL-60 human leukemia cells in spite of decreased cellular ara-CTP accumulation

Enhancement of IL-8 production from human monocytic and granulocytic cell lines, THP-1 and HL-60, stimulated with Malassezia furfur

Peroxisome Proliferator-Activated Receptor γ (PPAR-γ) Agonist Rosiglitazone (RGZ) Inhibits HL-60 Cell Growth by Induction of Apoptosis

Quercetin induces apoptosis by activating caspase-3 and regulating Bcl-2 and cyclooxygenase-2 pathways in human HL-60 cells

Participation of Cofilin in Opsonized Zymosan-Triggered Activation of Neutrophil-Like HL-60 Cells through Rapid Dephosphorylation and Translocation to Plasma Membranes

Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.

 

More Like This

Show all results sharing this subject:

  • Medicine and Health

GO

Show Summary Details

Quick Reference

A line of human promyelocytic cells established in 1977 from a patient with acute myeloid leukaemia. They are pluripotent and can be induced to differentiate into neutrophil or eosinophil-like cells by various treatments. The genome has an amplified c-myc proto-oncogene.

Subjects: Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.